TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23210764

Group type: EXPERIMENTAL
Intervention: Tuned waveform (3.5 milliseconds membrane time constant)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 50/50% tilt waveform
Number of subjects: 52
Study: 21843110

Group type: EXPERIMENTAL
Intervention: Immediate switch to levodopa/carbidopa/entacapone (LCE)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Delayed switch to levodopa/carbidopa/entacapone (LCE)
Number of subjects: 350
Study: 18587236

Group type: EXPERIMENTAL
Intervention: 50 mg i.v. 5‐MTHF
Number of subjects: 341

Group type: COMPARATOR
Intervention: 5 mg/day oral folic acid
Number of subjects: 341
Study: 16466331

Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire (intervention group)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Usual methods of referral (control group)
Number of subjects: 194
Study: 12644413

Group type: EXPERIMENTAL
Intervention: Clonidine premedication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flunitrazepam (control)
Number of subjects: 0
Study: 11813275

Group type: EXPERIMENTAL
Intervention: Mini Mental State Examination (MMSE) translated to Sinhalese
Number of subjects: 380

Group type: COMPARATOR
Intervention: Cognitively normal subjects (scored >17 on MMSE)
Number of subjects: 380
Study: 9732167

Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Terbinafine 500 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Overall relapse rate
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Relapse rates over time
Number of subjects: 47

Group type: COMPARATOR
Intervention: Comparison of relapse rates
Number of subjects: 47
Study: 8027279

Group type: EXPERIMENTAL
Intervention: Follicle Stimulating Hormone (FSH) 225 IU/day for 5 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal saline 2 ml/day for 5 days
Number of subjects: 10
Study: 2524571

Group type: EXPERIMENTAL
Intervention: Chlorhexidine dihydrochloride lozenges (5 mg, sucked three times daily after meals for 2 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo lozenges (all ingredients except chlorhex HCl)
Number of subjects: 21
Study: 29044395

Group type: EXPERIMENTAL
Intervention: Cholesterol lowering (mean reduction of about 1.0 mmol/L) in men with average cholesterol and no CHD
Number of subjects: 6595

Group type: EXPERIMENTAL
Intervention: Cholesterol lowering in men with a history of CHD
Number of subjects: 6595

Group type: COMPARATOR
Intervention: Lowest cholesterol group (mean 4.0 mmol/L)
Number of subjects: 6595

Group type: COMPARATOR
Intervention: Highest cholesterol group (mean 8.8 mmol/L)
Number of subjects: 6595
Study: 25816315

Group type: EXPERIMENTAL
Intervention: Inhaled UMEC/VI 62.5/25 μg (delivering 55/22 μg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Inhaled UMEC/VI 125/25 μg (delivering 113/22 μg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: UMEC 62.5 μg (monotherapy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: UMEC 125 μg (monotherapy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: VI 25 μg (monotherapy)
Number of subjects: 20
Study: 24074303

Group type: EXPERIMENTAL
Intervention: L. reuteri NCIMB 30242
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 21840164

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) + Venlafaxine XR
Number of subjects: 117

Group type: COMPARATOR
Intervention: Venlafaxine XR alone
Number of subjects: 117
Study: 18954956

Group type: EXPERIMENTAL
Intervention: Extensive information
Number of subjects: 100

Group type: COMPARATOR
Intervention: Minimal information
Number of subjects: 100
Study: 17908740

Group type: EXPERIMENTAL
Intervention: Nurse home visits
Number of subjects: 743

Group type: COMPARATOR
Intervention: Comparison services
Number of subjects: 743
Study: 15147075

Group type: EXPERIMENTAL
Intervention: STRESSEN for 30 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no specific therapy)
Number of subjects: 40
Study: 11569760

Group type: EXPERIMENTAL
Intervention: Manipulation of cognitive resources through time pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of cognitive resources through a concurrent tone task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 9768527

Group type: EXPERIMENTAL
Intervention: Alosetron 0.25 mg b.d.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Alosetron 4 mg b.d.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 7921222

Group type: EXPERIMENTAL
Intervention: Gonadotropins (1000-2500 IE hCG twice per week and 75-150 IE hMG three times per week)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone (GnRH) (5-20 micrograms every 120 min)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Gonadotropins or GnRH
Number of subjects: 26
Study: 31970675

Group type: EXPERIMENTAL
Intervention: Modified Liujunzi Decoction (MLJZT)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Cisplatin-based chemotherapy alone (Control group)
Number of subjects: 156
Study: 29937256

Group type: COMPARATOR
Intervention: Training workshop plus enhanced consultation (C+)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Training workshop with basic consultation (C)
Number of subjects: 14
Study: 27188910

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham electroacupuncture (n=30)
Number of subjects: 60
Study: 24366401

Group type: EXPERIMENTAL
Intervention: Enhanced care
Number of subjects: 1181

Group type: EXPERIMENTAL
Intervention: Health literacy‐informed education
Number of subjects: 1181

Group type: EXPERIMENTAL
Intervention: Education plus nurse support
Number of subjects: 1181

Group type: COMPARATOR
Intervention: Literacy‐informed education with nurse support
Number of subjects: 1181
Study: 21831489

Group type: EXPERIMENTAL
Intervention: Honey dressings
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional dressings (control)
Number of subjects: 70
Study: 20488885

Group type: EXPERIMENTAL
Intervention: Rituximab 2 x 500 mg + MTX
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Rituximab 2 x 1000 mg + MTX
Number of subjects: 512

Group type: COMPARATOR
Intervention: Placebo + MTX
Number of subjects: 512
Study: 18773726

Group type: EXPERIMENTAL
Intervention: In-car noise at real-world level
Number of subjects: 7

Group type: COMPARATOR
Intervention: Reduced in-car noise by 5 dB
Number of subjects: 7
Study: 16166411

Group type: EXPERIMENTAL
Intervention: Acute treatment for late-life depression with Cluster C PDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuation or maintenance treatment for late-life depression with Cluster C PDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maintenance treatment for late-life depression with Cluster C PDs and residual depressive symptoms
Number of subjects: 0
Study: 12963902

Group type: EXPERIMENTAL
Intervention: Acitretin 0.4 mg/kg/d for 1 year
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Acitretin 0.4 mg/kg/d for 3 months followed by 0.2 mg/kg/d for 9 months
Number of subjects: 26
Study: 10548673

Group type: EXPERIMENTAL
Intervention: Forced use therapy (immobilization of the unaffected arm combined with intensive training)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Bimanual training (reference therapy based on Neuro‐Developmental Treatment)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Forced use therapy
Number of subjects: 66
Study: 8724933

Group type: EXPERIMENTAL
Intervention: learner‐guided instructions
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: tutor‐guided instructions
Number of subjects: 90

Group type: COMPARATOR
Intervention: control group
Number of subjects: 90
Study: 1806627

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6313502

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg daily)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Cimetidine (1 g daily)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Ranitidine and Cimetidine
Number of subjects: 71
Study: 29487077

Group type: EXPERIMENTAL
Intervention: Multidimensional interdisciplinary lifestyle and psychosocial intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care during pregnancy and the first year postpartum
Number of subjects: 200
Study: 27385432

Group type: EXPERIMENTAL
Intervention: Episodic treatment pre-study followed by prophylaxis on-study
Number of subjects: 118

Group type: COMPARATOR
Intervention: Hyphenate prophylaxis
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Individualized or weekly prophylaxis in B-LONG
Number of subjects: 118

Group type: COMPARATOR
Intervention: Hyphenate prophylaxis in B-LONG
Number of subjects: 118
Study: 24292519

Group type: EXPERIMENTAL
Intervention: 6 mg/kg ATG
Number of subjects: 224

Group type: COMPARATOR
Intervention: 10 mg/kg ATG
Number of subjects: 224
Study: 21890719

Group type: EXPERIMENTAL
Intervention: Directly observed antiretroviral therapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 76
Study: 20634743

Group type: EXPERIMENTAL
Intervention: Static stretching (SS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Typical warm-up (TWU)
Number of subjects: 38
Study: 18377128

Group type: EXPERIMENTAL
Intervention: Dissonance-based thin-ideal internalization reduction program
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Healthy weight control program
Number of subjects: 481

Group type: COMPARATOR
Intervention: Expressive writing control condition
Number of subjects: 481

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 481
Study: 16036829

Group type: EXPERIMENTAL
Intervention: Voice Assist Manikin (VAM) system
Number of subjects: 114
Study: 11796426

Group type: EXPERIMENTAL
Intervention: Internal cardioversion (CV)
Number of subjects: 63

Group type: COMPARATOR
Intervention: External cardioversion (CV)
Number of subjects: 63
Study: 10072696

Group type: EXPERIMENTAL
Intervention: Forced talk group (discussed both sets of films with at least three people)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No talk group (instructed not to discuss the films)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Talkers group (did not comply with instructions to not discuss the films)
Number of subjects: 0
Study: 7745506

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (5 ml/kg dose)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant
Number of subjects: 215

Group type: COMPARATOR
Intervention: Synthetic surfactant and Air placebo
Number of subjects: 215
Study: 2183254

Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7006402

Group type: EXPERIMENTAL
Intervention: Polymacon spin‐cast lenses
Number of subjects: 10

Group type: COMPARATOR
Intervention: Polymacon lathe‐cut lenses
Number of subjects: 10
Study: 31041358

Group type: EXPERIMENTAL
Intervention: Danirixin 15mg IV bid + Oseltamivir 75mg bid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Danirixin 50mg IV bid + Oseltamivir 75mg bid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo IV bid + Oseltamivir 75mg bid
Number of subjects: 10
Study: 29108794

Group type: EXPERIMENTAL
Intervention: Customized cutting block (CCB)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional cutting instrument (CCI)
Number of subjects: 108
Study: 27353112

Group type: EXPERIMENTAL
Intervention: Negative emotional memory retrieval
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test
Number of subjects: 91
Study: 24597931

Group type: EXPERIMENTAL
Intervention: Methylene blue-assisted technique (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard technique (Group A)
Number of subjects: 60
Study: 22342011

Group type: EXPERIMENTAL
Intervention: Double-gloving
Number of subjects: 218

Group type: COMPARATOR
Intervention: Single-gloving
Number of subjects: 218

Group type: COMPARATOR
Intervention: Single-gloving (first assistants)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Single-gloving (scrub nurses)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Double-gloving (first assistants)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Double-gloving (scrub nurses)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Overall perforation occurrence
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Perforation sites
Number of subjects: 218
Study: 20853059

Group type: EXPERIMENTAL
Intervention: IORT with EBRT
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: IORT alone
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: IORT
Number of subjects: 69

Group type: COMPARATOR
Intervention: EBRT
Number of subjects: 69
Study: 18397688

Group type: EXPERIMENTAL
Intervention: Cefepime 2 g A 2
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Cefepime 4 g continuously
Number of subjects: 55

Group type: COMPARATOR
Intervention: Model validation
Number of subjects: 55
Study: 15978440

Group type: EXPERIMENTAL
Intervention: Trained group (videotrainer suturing model)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 17
Study: 14578781

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight dextran 20 cc/hour for 48 hours (n=35)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight dextran 20 cc/hour for 120 hours (n=32)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aspirin 325 mg/day for 120 hours (n=27)
Number of subjects: 100
Study: 11078287

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 8809502

Group type: EXPERIMENTAL
Intervention: Fluoxetine, 40 mg/day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 1551795

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (75 mg, intramuscular injection)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Paracetamol (intramuscular injection)
Number of subjects: 86
Study: 3083922

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (ESWL)
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy and ESWL
Number of subjects: 1052
Study: 31116180

Group type: EXPERIMENTAL
Intervention: MenACWY-TT
Number of subjects: 0
Study: 29239965

Group type: EXPERIMENTAL
Intervention: A.P. Advance
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: C-MAC PM
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: KingVision
Number of subjects: 168
Study: 26760174

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (12 months)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (0, 5, and 12 months)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Lean reference subjects (baseline)
Number of subjects: 19
Study: 25410432

Group type: EXPERIMENTAL
Intervention: Attending outpatient colorectal clinic
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-attending students
Number of subjects: 36
Study: 22136516

Group type: EXPERIMENTAL
Intervention: DHEA-S (100 mg daily for 3 months)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 20701787

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intensive Insulin Treatment (IIT)
Number of subjects: 24
Study: 17062655

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (EE)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control interventions (e.g., concentric exercise (CE), stretching, splinting, frictions, ultrasound)
Number of subjects: 11
Study: 16003612

Group type: EXPERIMENTAL
Intervention: Bioresorbable guided tissue regeneration (GTR) therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Demineralized bone powder (DBP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 12
Study: 11886971

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 45
Study: 10440592

Group type: EXPERIMENTAL
Intervention: Sibutramine (133 patients, 72 in double-blind period)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo (77 patients)
Number of subjects: 210
Study: 8745803

Group type: EXPERIMENTAL
Intervention: Early mobilization with flexible casting after 3 weeks in plaster casts for 2 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional short-arm, below the elbow plaster of Paris casts for 5 weeks
Number of subjects: 90
Study: 2335101

Group type: EXPERIMENTAL
Intervention: EE/LN (levonorgestrel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SHG 415G (gestodene)
Number of subjects: 0
Study: 378804

Group type: EXPERIMENTAL
Intervention: 193 mg Fe++ daily for 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 90
Study: 30907187

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) 2 or 4 IU daily subcutaneous injection
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) 4 IU - 6 weeks pretreatment
Number of subjects: 1562

Group type: COMPARATOR
Intervention: Control group (no GH treatment)
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) 2PN rate
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) high-quality embryo rate
Number of subjects: 1562
Study: 27109856

Group type: EXPERIMENTAL
Intervention: Spiritual well-being measured by the FACIT-Sp (both M&P and Faith scales)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) assessed by the Neuro-QOL PAWB scale
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Depression assessed by the Patient Health Questionnaire-9 (PHQ-9)
Number of subjects: 204
Study: 26119226

Group type: EXPERIMENTAL
Intervention: 2 mg/kg golimumab
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: 4 mg/kg golimumab
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 24722160

Group type: EXPERIMENTAL
Intervention: Vandetanib plus gemcitabine (V/G)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Gemcitabine plus placebo
Number of subjects: 124
Study: 22301679

Group type: EXPERIMENTAL
Intervention: MAPSS‐MS intervention (eight‐week program with weekly group sessions and computer‐assisted training)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: MAPSS‐MS intervention
Number of subjects: 61
Study: 19067772

Group type: EXPERIMENTAL
Intervention: Mock-crime group (participants who damaged and stole CDs)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No-crime group (participants who did not perform a task)
Number of subjects: 36
Study: 17470858

Group type: EXPERIMENTAL
Intervention: Panitumumab plus best supportive care (BSC)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Panitumumab after crossover from BSC
Number of subjects: 463
Study: 15099656

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 12060017

Group type: EXPERIMENTAL
Intervention: Retraining Method
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Compensation Method
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 50
Study: 9808597

Group type: EXPERIMENTAL
Intervention: Baseline ECG ST-T changes and biochemical markers (TnT, TnI, CK-MB mass, myoglobin)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: ST-segment depression, inverted T waves in >/=5 leads, TnT >/=0.1 microg/L, TnI >/=0.5 microg/L, myoglobin >/=40 microg/L, female sex, age >/=65 years
Number of subjects: 516
Study: 7710149

Group type: EXPERIMENTAL
Intervention: 6 mg sumatriptan SC
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 2560514

Group type: EXPERIMENTAL
Intervention: Oral THC (10 mg t.i.d. for 3 days and on the morning of the fourth day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Higher doses of THC by inhalation (18 mg/marijuana cigarette)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Heavy THC users
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Light THC users
Number of subjects: 17
Study: 6166128

Group type: EXPERIMENTAL
Intervention: Antibiotics combined with pepsin-treated human gamma globulin (Gamma-Venin)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 146
Study: 31977883

Group type: EXPERIMENTAL
Intervention: LC09 Granules
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 31597652

Group type: EXPERIMENTAL
Intervention: whole milk + RE
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: skimmed milk + RE
Number of subjects: 30

Group type: COMPARATOR
Intervention: control drink + RE
Number of subjects: 30
Study: 27553588

Group type: EXPERIMENTAL
Intervention: New resuscitation system with face mask
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: New resuscitation system with nasal prongs
Number of subjects: 36

Group type: COMPARATOR
Intervention: T-piece resuscitation system
Number of subjects: 36
Study: 25876977

Group type: EXPERIMENTAL
Intervention: Central venous catheter (PICC) group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional puncture group
Number of subjects: 104
Study: 24227799

Group type: EXPERIMENTAL
Intervention: Daily real-time teleconsultations for one week between hospital-based nurses and patients with severe COPD (n=132)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (n=134)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Secondary analysis for both groups
Number of subjects: 266